The Future of Technology In 2026 and Beyond
Over the past decade, the tech sector has tended to rebound after bouts of underperformance, about 80% of the time, historically. This year looked like another chapter in that same story: short-term skepticism giving way to renewed conviction.
Now, as we move into the final quarter of 2025, several massive forces are quietly re-shaping the landscape.
» Read more about: The Future of Technology In 2026 and Beyond »
Read More
The Monopoly Behind AI Chips
If you want to understand the real bottleneck in semiconductors, it isn’t wafers, fabs, or even chip designers like Nvidia. It’s the machines that etch impossibly small patterns onto silicon. And in that game, there’s just one winner, ASML.
ASML isn’t just another chip equipment supplier. It has something no one else on Earth can build,
» Read more about: The Monopoly Behind AI Chips »
Read More
Is Monday THE Operating System for Work?
Monday.com sits right in the middle of this transformation, and if management gets its way, it won’t just be a participant. It wants to be the work operating system for the modern enterprise.
For companies running cross-functional projects, think engineering, sales, marketing, and operations all under one roof, Monday offers a centralized dashboard where tasks can be assigned automatically,
» Read more about: Is Monday THE Operating System for Work? »
Read More
The Giant at the Intersection of AI, Networking and Software
Broadcom isn’t just another chipmaker riding the semiconductor cycle, it’s a carefully assembled portfolio of some of the stickiest, most profitable businesses in tech.
At its core, Broadcom has mastered the art of acquisition, folding niche leaders into its empire, stripping out inefficiencies, and using the resulting free cash flow to fuel dividends,
» Read more about: The Giant at the Intersection of AI, Networking and Software »
Read More
Pfizer’s Big Win Means What For Investors?
Pfizer just pulled off a big deal as it relates to the pharmaceutical landscape in the U.S. On Tuesday, the CEO announced a wide-ranging agreement with the Trump administration that will lower drug prices for many Americans.
At the center of this deal is a new government-backed portal called “TrumpRx”, a website designed to help patients access discounted prescription drugs by connecting them directly to manufacturers’ platforms.
» Read more about: Pfizer’s Big Win Means What For Investors? »
Read MoreThe Ivy
Ken Griffin’s Big Trim in Palantir
In the second quarter of 2025, Ken Griffin’s Citadel Advisors sharply reduced its holding in Palantir Technologies, selling nearly half of its position.
The move raised about $75 million in cash and followed a familiar pattern for Griffin, who has been building and trimming his Palantir stake in waves since 2021.
This latest sale has investors wondering: why would one of Wall Street’s most sophisticated fund managers cut exposure to a stock riding the artificial intelligence boom?
» Read more about: Ken Griffin’s Big Trim in Palantir »
Read MoreThe Spotlight
Costco’s Secret Profit Engine
Beneath the surface, Costco isn’t just about cheap gas, hot dogs, and fancy electronics, but the financial engine is far less obvious, and far more powerful than most casual shoppers realize.
If you’re thinking about buying Costco stock, understanding these three fundamentals could change how you see the company’s long-term investment case.
Key Points
-
Annual fees generate the majority of net income,
» Read more about: Costco’s Secret Profit Engine »
Read MoreThe Daily
Stock market today: Nasdaq, S&P 500, Dow sink as another tech sell-off has stocks on track for brutal week
US stocks faltered in their rebound bid on Friday, resuming a tech-led sell-off as investors weighed bearish consumer sentiment data and the odds that the AI investment boom will pay off.
The tech-heavy Nasdaq Composite (^IXIC) led the losses, falling around 1.8% following Thursday’s sharp losses for US gauges.